0001209191-18-008227.txt : 20180207
0001209191-18-008227.hdr.sgml : 20180207
20180207182606
ACCESSION NUMBER: 0001209191-18-008227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180205
FILED AS OF DATE: 20180207
DATE AS OF CHANGE: 20180207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18582282
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2018-02-05
4
M
0
1942
86.52
A
41105
D
Common Stock
2018-02-05
4
M
0
2578
77.31
A
43683
D
Common Stock
2018-02-05
4
S
0
378
158.55
D
43305
D
Common Stock
2018-02-05
4
S
0
700
159.93
D
42605
D
Common Stock
2018-02-05
4
S
0
300
160.97
D
42305
D
Common Stock
2018-02-05
4
S
0
300
161.93
D
42005
D
Common Stock
2018-02-05
4
S
0
600
163.79
D
41405
D
Common Stock
2018-02-05
4
S
0
2242
164.93
D
39163
D
Common Stock
882
I
401(k)
Common Stock
12215
I
Held in Trust
Stock Option (Right to Buy)
86.52
2018-02-05
4
M
0
1942
0.00
D
2027-02-02
Common Stock
1942
23299
D
Stock Option (Right to Buy)
77.31
2018-02-05
4
M
0
2578
0.00
D
2024-02-04
Common Stock
2578
0
D
Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $158.55 (range $158.24 to $159.09).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $159.93 (range $159.46 to $160.47).
Open market sales reported on this line occurred at a weighted average price of $160.97 (range $160.51 to $161.26).
Open market sales reported on this line occurred at a weighted average price of $161.93 (range $161.70 to $162.39).
Open market sales reported on this line occurred at a weighted average price of $163.79 (range $163.23 to $164.22).
Open market sales reported on this line occurred at a weighted average price of $164.93 (range $164.31 to $165.06).
The option vests in 16 quarterly installments from 2/3/2017.
Fully vested.
/s/ Omar White, Attorney-in-Fact
2018-02-07